| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 02/08/1996 | WO1996003515A2 Surface expression of enzyme in gene directed prodrug therapy |
| 02/08/1996 | WO1996003501A1 Dual hybrid system |
| 02/08/1996 | WO1996003499A1 Receptor-ligand assay |
| 02/08/1996 | WO1996003437A1 PTH OR PTHrP ANTAGONISTS |
| 02/08/1996 | WO1996003421A1 Neurologically active aminosteroids |
| 02/08/1996 | WO1996003415A1 Human potassium channel 1 and 2 proteins |
| 02/08/1996 | WO1996003407A1 Compounds useful as antiproliferative agents and garft inhibitors |
| 02/08/1996 | WO1996003406A1 Compounds useful as antiproliferative agents and garft inhibitors |
| 02/08/1996 | WO1996003401A2 Process for the production of aminoazobicycloalkanes from oximes |
| 02/08/1996 | WO1996003400A1 4-indole derivatives as serotonin agonists and antagonists |
| 02/08/1996 | WO1996003399A1 Dihydrobenzofuranes |
| 02/08/1996 | WO1996003396A1 Dihydrobenzofuran and related compounds useful as anti-inflammatory agents |
| 02/08/1996 | WO1996003388A1 1,2-substituted imidazolyl compounds for the treatment of inflammation |
| 02/08/1996 | WO1996003383A1 INDOLIZINE sPLA2 INHIBITORS |
| 02/08/1996 | WO1996003376A1 1H-INDOLE-1-FUNCTIONAL sPLA2 INHIBITORS |
| 02/08/1996 | WO1996003151A2 Intracellular expression of carboxypeptidase g2 in enzyme prodrug therapy |
| 02/08/1996 | WO1996003149A1 Antifungal-wound healing compositions and methods for preparing and using same |
| 02/08/1996 | WO1996003148A1 Method and drug for treating diabetes |
| 02/08/1996 | WO1996003146A1 Retroviral transduction of cells using soluble complement inhibitors |
| 02/08/1996 | WO1996003122A2 Use of gabapentin in the treatment of anxiety and panic |
| 02/08/1996 | WO1996003120A1 INDENE sPLA2 INHIBITORS |
| 02/08/1996 | WO1995022611A3 Methods and compositions for stimulating bone cells |
| 02/08/1996 | DE4427648A1 N-Stubstituierte 3-Azabicyclo[3,2,0,]heptan-Derivate, ihre Herstellung und Verwendung N-Stubstituierte 3-azabicyclo [3,2,0,] heptane derivatives, their preparation and use |
| 02/08/1996 | DE4427647A1 N-substituierte Azabicycloheptan-Derivate, ihre Herstellung und Verwendung N-substituted Azabicycloheptan derivatives, their preparation and use |
| 02/08/1996 | CA2196052A1 Intracellular expression of carboxypeptidase g2 in enzyme prodrug therapy |
| 02/08/1996 | CA2196051A1 Surface expression of enzyme in gene directed prodrug therapy |
| 02/08/1996 | CA2195845A1 1,2-substituted imidazolyl compounds for the treatment of inflammation |
| 02/08/1996 | CA2195800A1 Receptor-ligand assay |
| 02/08/1996 | CA2195570A1 Indolizine spla2 inhibitors |
| 02/08/1996 | CA2195569A1 1h-indole-1-functional spla2 inhibitors |
| 02/08/1996 | CA2195432A1 Indene spla2 inhibitors |
| 02/08/1996 | CA2195420A1 Compounds useful as antiproliferative agents and garft inhibitors |
| 02/08/1996 | CA2194973A1 Retroviral transduction of cells using soluble complement inhibitors |
| 02/08/1996 | CA2192787A1 Pth or pthrp antagonists |
| 02/08/1996 | CA2191603A1 Antifungal-wound healing compositions and methods for preparing and using same |
| 02/07/1996 | EP0695355A1 Protein having tpo activity |
| 02/07/1996 | EP0695305A1 Method of forming oligonucleotides |
| 02/07/1996 | EP0695189A1 Treatment of inflammatory bowel disease with ifn-gamma inhibitors |
| 02/07/1996 | EP0695187A1 Compositions for inhibition, control and regression of angiogenesis, containing hyaluronic acid and nsaid |
| 02/07/1996 | EP0695180A1 Novel medical use for gaba agonists |
| 02/07/1996 | EP0611368B1 Substituted aminopyrimidines as angiotensin ii antagonists |
| 02/07/1996 | EP0502049B1 Tumour necrosis factor antagonist |
| 02/07/1996 | EP0470251B1 Liquid prostaglandin composition |
| 02/07/1996 | CN1116114A Wuji (black-bone chicken) tonic liquid |
| 02/07/1996 | CN1030915C Method for preparation of benzimidazole derivatives |
| 02/06/1996 | US5489604 Treating degenerative diseases |
| 02/06/1996 | US5489592 3,4-dihydro-4-oxo-3-(2-propenyl)-1-phthalazineacetic acids and derivatives, their preparations and medicines containing them |
| 02/06/1996 | US5489587 Benzofurans used to inhibit bone loss |
| 02/06/1996 | US5489579 Potentation of NMDA antagonists |
| 02/06/1996 | US5489508 Therapy and diagnosis of conditions related to telomere length and/or telomerase activity |
| 02/05/1996 | CA2155245A1 Use of neutortensin antagonists for the preparation of diuretic drugs |
| 02/05/1996 | CA2155143A1 Method of promoting hair growth |
| 02/01/1996 | WO1996002643A1 Denervated muscle kinase (dmk), a receptor of the tyrosine kinase super family |
| 02/01/1996 | WO1996002571A1 Concentrate of fibrinogene obtained from blood plasma, process and plant for its preparation |
| 02/01/1996 | WO1996002565A1 Igf/igfbp complex for promoting bone formation and for regulating bone remodeling |
| 02/01/1996 | WO1996002559A1 Growth differentiation factor-12 |
| 02/01/1996 | WO1996002558A1 Linked peptide nucleic acids |
| 02/01/1996 | WO1996002555A1 Immunomodulatory oligonucleotides |
| 02/01/1996 | WO1996002545A1 Heterocycle-condensed morphinoid derivatives |
| 02/01/1996 | WO1996002544A1 IMIDAZO[1,2-a]INDENO[1,2-e]PYRAZINE-2-CARBOXYLIC ACID DERIVATIVES, PREPARATION THEREOF AND DRUGS CONTAINING SAME |
| 02/01/1996 | WO1996002537A1 Benzocondensed five membered heterocycle carboxamides as 5ht2b/2c receptor antagonists |
| 02/01/1996 | WO1996002535A1 Process for synthesis of substituted sulphoxides |
| 02/01/1996 | WO1996002507A1 Iminoxycarboxylates and derivatives as inhibitors of leukotriene biosynthesis |
| 02/01/1996 | WO1996002501A1 SYNTHESIS OF 1α-HYDROXY VITAMIN D |
| 02/01/1996 | WO1996002499A1 Difluorostatone antiviral agents |
| 02/01/1996 | WO1996002497A1 Substituted benzamidines, their production and their use as medicaments |
| 02/01/1996 | WO1996002496A1 Novel chemical compound, its preparation and use as a drug |
| 02/01/1996 | WO1996002267A1 Peptide, a method of obtaining it and a pharmaceutical compound based on it |
| 02/01/1996 | WO1996002260A1 Wound healing agent |
| 02/01/1996 | WO1996002259A1 Hard tissue stimulating agent |
| 02/01/1996 | WO1996002258A1 Anti-adhesion agent |
| 02/01/1996 | WO1996002257A1 Antisense oligonucleotides of pleiotrophin |
| 02/01/1996 | WO1996002251A1 Method of simultaneously enhancing analgesic potency and attenuating dependence liability caused by exogenous and endogenous opioid agonists |
| 02/01/1996 | WO1996002248A1 Cannabinoid receptor antagonists |
| 02/01/1996 | WO1996002245A1 Nitric oxide synthase inhibitors for inhibiting the production of airway mucus |
| 02/01/1996 | WO1996002241A1 Use of nitrogen oxide species and adducts to inhibit skeletal muscle contraction |
| 02/01/1996 | WO1996002240A2 Use of inhibitors of human s-cd23 |
| 02/01/1996 | WO1995026739A3 Use of substituted dextranes for treating nervous system damage, and heparane sulphate-enriched fractions |
| 02/01/1996 | DE19527140A1 Sprühbare Lösungen mit blutdrucksenkender Wirkung und Verfahren zu ihrer Herstellung sowie ihre Verwendung Sprayable solutions with antihypertensive effect and process for their preparation and their use |
| 02/01/1996 | CA2560114A1 Immunomodulatory oligonucleotides |
| 02/01/1996 | CA2195474A1 Igf/igfbp complex for promoting bone formation and for regulating bone remodeling |
| 02/01/1996 | CA2195450A1 Antisense oligonucleotides of pleiotrophin |
| 02/01/1996 | CA2195246A1 Growth differentiation factor-12 |
| 02/01/1996 | CA2195122A1 Method of simultaneously enhancing analgesic potency and attenuating dependence liability caused by exogenous and endogenous opioid agonists |
| 02/01/1996 | CA2194991A1 Use of nitrogen oxide species and adducts to inhibit skeletal muscle contraction |
| 02/01/1996 | CA2194886A1 Novel chemical compound, its preparation and use as a drug |
| 02/01/1996 | CA2194877A1 Heterocycle-condensed morphinoid derivatives |
| 02/01/1996 | CA2194684A1 Cannabinoid receptor antagonists |
| 02/01/1996 | CA2191975A1 Iminoxycarboxylates and derivatives as inhibitors of leukotriene biosynthesis |
| 01/31/1996 | EP0694561A1 Calcitonin analogue and use thereof |
| 01/31/1996 | EP0694547A2 2-(2-amino-1,6-dihydro-6-oxo-purin-9-yl)methoxy-1,3-propanediol derivative |
| 01/31/1996 | EP0694546A2 Substituted dibenzoxazepine compounds, pharmaceutical compositions and methods of use |
| 01/31/1996 | EP0694545A2 Substituted dibenzoxazepine compounds, pharmaceutical compositions and methods of use |
| 01/31/1996 | EP0694542A1 Process for racemisation of enantiomers of alpha-lipoic acid |
| 01/31/1996 | EP0694535A1 Non-peptidyl tachykinin receptor antagonists |
| 01/31/1996 | EP0694307A1 Atopic disease remedy |
| 01/31/1996 | EP0694302A1 Compositions containing insaturated fatty acids and an aldose reductase inhibitor for treatment of diabetic complications |
| 01/31/1996 | EP0694301A1 Synergistic combination containing at least a RXR specific ligand and a RAR alpha specific ligand |
| 01/31/1996 | EP0694299A1 The use of( a) bicycloheptane derivative(s) |
| 01/31/1996 | EP0694078A1 Method for screening for receptor agonists |